{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Gastrointestinal epithelial barrier disorders",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_mesalazine",
          "name": "Mesalazine"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_budesonide",
          "name": "Budesonide"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_azathioprine",
          "name": "Azathioprine"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_tacrolimus",
          "name": "Tacrolimus"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_natalizumab",
          "name": "Natalizumab"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_vedolizumab",
          "name": "Vedolizumab"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_ustekinumab",
          "name": "Ustekinumab"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_5_aminosalicylic_acid",
          "name": "5-Aminosalicylic Acid"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_oral_corticosteroids",
          "name": "Oral Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mesalazine",
          "type": "Drug",
          "label": "Mesalazine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_budesonide",
          "type": "Drug",
          "label": "Budesonide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tacrolimus",
          "type": "Drug",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_natalizumab",
          "type": "Drug",
          "label": "Natalizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_vedolizumab",
          "type": "Drug",
          "label": "Vedolizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_5_aminosalicylic_acid",
          "type": "Drug",
          "label": "5-Aminosalicylic Acid",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_oral_corticosteroids",
          "type": "Drug",
          "label": "Oral Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Phenotype_Gastrointestinal_disorder",
          "type": "Phenotype",
          "label": "Gastrointestinal epithelial barrier disorders",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_infliximab",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知用于治疗的药物，具备良好疗效"
        },
        {
          "source": "drug_mesalazine",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "相关文献支持其用于此表型"
        },
        {
          "source": "drug_budesonide",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "具有相似用途，临床应用常见"
        },
        {
          "source": "drug_azathioprine",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "用于 autoimmune diseases，有潜在益处"
        },
        {
          "source": "drug_adalimumab",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "针对炎症性疾病的靶向药物"
        },
        {
          "source": "drug_tacrolimus",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "免疫抑制剂，可能有治疗潜力"
        },
        {
          "source": "drug_natalizumab",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "相关研究显示其潜在效果"
        },
        {
          "source": "drug_vedolizumab",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "靶向治疗特定类型的疾病"
        },
        {
          "source": "drug_methotrexate",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "在自身免疫疾病中使用"
        },
        {
          "source": "drug_ustekinumab",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "针对特定病理机制的治疗"
        },
        {
          "source": "drug_5_aminosalicylic_acid",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "用于炎症性肠病的基本治疗"
        },
        {
          "source": "drug_oral_corticosteroids",
          "target": "Phenotype_Gastrointestinal_disorder",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "常用于急性症状的治疗"
        }
      ]
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多个药物可用于治疗胃肠上皮屏障障碍的表型",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "药物应具备到达胃肠道的有效性和安全性"
    ],
    "uncertainties": [
      "不同药物的个体耐受性及疗效可能存在差异"
    ],
    "next_focus_for_pi": [
      "是否需要考虑更多对照研究以验证疗效"
    ]
  }
}